GLP-1 Users Get Surgery for 'Ozempic Ears' Side Effect
Patients using GLP-1 weight loss medications are seeking surgical interventions to correct 'Ozempic ears' and other facial aging effects.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
GLP-1 weight loss led to new facial aging challenges, including "floppy" earlobes. Some users sought surgery to fix these "Ozempic ears" while others focused on preventing "Ozempic face."
Epilogue added 3d ago, after coverage quieted.
The brief
A new trend in medical aesthetics is emerging as individuals using GLP-1 weight loss medications seek surgical corrections for a condition referred to as 'Ozempic ears.' According to reports from The Daily Beast and the New York Post, patients are undergoing procedures to fix earlobes that have become 'floppy' and 'old-looking' following significant weight loss. These surgical interventions are aimed at addressing the physical changes in the earlobes that occur as a side effect of the rapid weight loss associated with these medications. The phenomenon is part of a broader set of aesthetic challenges involving the face and skin quality after GLP-1 use. The coverage of this trend is highlighted by an exclusive report from the New York Post, which focuses specifically on the surgical pursuit to repair the earlobes. The Daily Beast further validates this trend by reporting that users are actively getting surgery for this specific side effect.
Additionally, Halton Hills News reports that GLP weight loss is creating new and distinct facial aging challenges for patients. Yahoo has also contributed to the discourse by noting that there is an ongoing process of learning how to prevent the separate but related phenomenon known as 'Ozempic face.' Understanding this trend requires context regarding the systemic impact of GLP-1 medications on body composition. While these drugs are used for weight loss, the speed and volume of weight reduction can lead to a loss of subcutaneous fat and skin elasticity. This process manifests in various parts of the head and neck, leading to the 'floppy' appearance of the earlobes mentioned in the New York Post and the general facial aging described by Halton Hills News. The industry is currently attempting to identify preventative measures for these changes, as noted in the coverage from Yahoo regarding 'Ozempic face.' Moving forward, observers should watch for more detailed medical guidance on preventing these facial changes before they require surgical intervention.
Since Yahoo reports that experts are currently learning how to prevent 'Ozempic face,' future developments may include new preventative protocols. The focus remains on the surgical outcomes for those already experiencing 'Ozempic ears' and whether these procedures become a standardized part of the GLP-1 patient journey as more people undergo rapid weight loss. Coverage does not yet specify the long-term success rates or the specific types of surgical techniques being employed to fix the earlobes.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 44d ago.
Quick answers
What are 'Ozempic ears'?
They are 'floppy,' old-looking earlobes that occur as a side effect of weight loss from GLP-1 medications.
How are people treating this side effect?
According to the New York Post and The Daily Beast, people are getting surgery to fix their earlobes.
Is this the only facial side effect reported?
No, coverage from Yahoo and Halton Hills News also mentions 'Ozempic face' and general facial aging challenges.
Coverage (4)
- We're learning how to prevent 'Ozempic face' Yahoo · 91d ago
- Exclusive | People are getting surgery to fix their ‘floppy,’ old-looking ‘Ozempic earlobes’ after GLP-1 weight loss New York Post · 91d ago
- GLP weight loss creates new facial aging challenges! Halton Hills News · 91d ago
- GLP-1 Users Get Surgery for 'Ozempic Ears' Side Effect The Daily Beast · 91d ago
Topics
Related trends
Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
GLP-1 prescriptions for kids up more than 30,000% since 2019
Prescriptions for GLP-1 medications among children in the United States have surged by over 30,000% since 2019.
GLP-1 weight-loss drugs show promise for sleep apnea
Recent coverage highlights a potential new therapeutic benefit for GLP-1 weight-loss drugs regarding sleep apnea.
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Novo Nordisk faces a strategic divide as its childhood obesity drug succeeds in trials while its heart drug program suffers multiple terminations.
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Concerns grow over the efficacy of weight-loss injections and the severe withdrawal-like cravings some patients experience when the drugs fail.